Immediate Impact
54 standout
Citing Papers
Mitochondrial dysfunction: mechanisms and advances in therapy
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Eugene McLaurin being referenced
Lifitegrast Ophthalmic Solution 5.0% for Treatment of Dry Eye Disease
2013
A Phase 2 Randomized, Double-Masked, Placebo-Controlled Study of a Novel Integrin Antagonist (SAR 1118) for the Treatment of Dry Eye
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Eugene McLaurin | 441 | 316 | 208 | 26 | 637 | |
| David Wirta | 384 | 340 | 97 | 40 | 701 | |
| Eduardo Uchiyama | 500 | 275 | 98 | 25 | 683 | |
| Gregg J. Berdy | 478 | 273 | 236 | 32 | 699 | |
| Ipek Özer Stillman | 554 | 221 | 237 | 14 | 645 | |
| Enrique Adan Sato | 434 | 312 | 94 | 17 | 595 | |
| Zhengri Li | 379 | 150 | 63 | 17 | 521 | |
| Philipp B. Baenninger | 362 | 230 | 130 | 35 | 690 | |
| Jutta Horwath‐Winter | 557 | 296 | 101 | 36 | 720 | |
| Zhitao Su | 338 | 153 | 102 | 30 | 618 | |
| Charles Leahy | 590 | 264 | 70 | 27 | 734 |
All Works
Login with ORCID to disown or claim papers
Loading papers...